| Dr Pei-ling Chen, MD, PHD | |
|
660 S Euclid Ave, Saint Louis, MO 63110-1010 | |
| (314) 747-3000 | |
| Not Available |
| Full Name | Dr Pei-ling Chen |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 21 Years |
| Location | 660 S Euclid Ave, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033419007 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 2010017215 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc | 2264337021 | 920 |
News Archive
Since its discovery in 1989, hepatitis C virus (HCV) has been recognized as a major cause of chronic liver disease worldwide. The most recent WHO estimate of the prevalence of HCV infection is 2%, representing . about 150 million people. Every year, 3–4 million new people are infected with the hepatitis C virus, of those, approximately 60–80% develop chronic hepatitis, and 30% of them progress to cirrhosis and to end-stage liver disease.
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People's Republic of China.
Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.
Patients with Medicare or Medicaid, the uninsured, the elderly and the critically ill are the heaviest users of ambulances for transport to the emergency department, making them most vulnerable during periods of ambulance diversion. The results of a study of more than 30,000 patients taken to emergency departments by ambulance were published online Friday in Annals of Emergency Medicine ("At-Risk Populations and the Critically Ill Rely Disproportionately on Ambulance Transport to Emergency Departments").
Researchers in the USA have re-examined current testing and quarantining regimens for SARS-CoV-2. They suggest that the RT-PCR method and 14-day isolation rule may not be the most effective approach in managing viral transmission.
› Verified 3 days ago
| Entity Name | H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306833595 PECOS PAC ID: 2264337021 Enrollment ID: O20031204000575 |
News Archive
Since its discovery in 1989, hepatitis C virus (HCV) has been recognized as a major cause of chronic liver disease worldwide. The most recent WHO estimate of the prevalence of HCV infection is 2%, representing . about 150 million people. Every year, 3–4 million new people are infected with the hepatitis C virus, of those, approximately 60–80% develop chronic hepatitis, and 30% of them progress to cirrhosis and to end-stage liver disease.
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People's Republic of China.
Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.
Patients with Medicare or Medicaid, the uninsured, the elderly and the critically ill are the heaviest users of ambulances for transport to the emergency department, making them most vulnerable during periods of ambulance diversion. The results of a study of more than 30,000 patients taken to emergency departments by ambulance were published online Friday in Annals of Emergency Medicine ("At-Risk Populations and the Critically Ill Rely Disproportionately on Ambulance Transport to Emergency Departments").
Researchers in the USA have re-examined current testing and quarantining regimens for SARS-CoV-2. They suggest that the RT-PCR method and 14-day isolation rule may not be the most effective approach in managing viral transmission.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pei-ling Chen, MD, PHD 660 S Euclid Ave, Saint Louis, MO 63110-1010 Ph: (314) 747-3000 | Dr Pei-ling Chen, MD, PHD 660 S Euclid Ave, Saint Louis, MO 63110-1010 Ph: (314) 747-3000 |
News Archive
Since its discovery in 1989, hepatitis C virus (HCV) has been recognized as a major cause of chronic liver disease worldwide. The most recent WHO estimate of the prevalence of HCV infection is 2%, representing . about 150 million people. Every year, 3–4 million new people are infected with the hepatitis C virus, of those, approximately 60–80% develop chronic hepatitis, and 30% of them progress to cirrhosis and to end-stage liver disease.
U.S. Secretary of Health and Human Services (HHS) Mike Leavitt signed a Joint Progress Statement today with the Honorable Li Changjiang, Minister of the General Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) of the People's Republic of China.
Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.
Patients with Medicare or Medicaid, the uninsured, the elderly and the critically ill are the heaviest users of ambulances for transport to the emergency department, making them most vulnerable during periods of ambulance diversion. The results of a study of more than 30,000 patients taken to emergency departments by ambulance were published online Friday in Annals of Emergency Medicine ("At-Risk Populations and the Critically Ill Rely Disproportionately on Ambulance Transport to Emergency Departments").
Researchers in the USA have re-examined current testing and quarantining regimens for SARS-CoV-2. They suggest that the RT-PCR method and 14-day isolation rule may not be the most effective approach in managing viral transmission.
› Verified 3 days ago
Dr. Erin Elizabeth Ely, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1300 Clark Ave, Saint Louis, MO 63103 Phone: 314-622-4971 Fax: 314-977-7615 | |
Dr. Richard Justin Perrin, MD Pathology Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Div Pa Anatomic And Molecular Path, Saint Louis, MO 63110 Phone: 314-362-5641 Fax: 314-362-0369 | |
Dr. Shouying Du, M.D Pathology Medicare: Accepting Medicare Assignments Practice Location: 6420 Clayton Rd, Saint Louis, MO 63117 Phone: 314-344-7525 Fax: 314-344-7226 | |
Virgilio P Dumadag, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3015 N Ballas Rd, Department Of Pathology, Saint Louis, MO 63131 Phone: 314-996-4285 Fax: 314-996-5551 | |
Alexander D Babich, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 6420 Clayton Rd, Saint Louis, MO 63117 Phone: 314-768-8202 Fax: 314-768-7145 | |
Mary A. Rudloff, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 11133 Dunn Rd, Dept. Of Pathology, Saint Louis, MO 63136 Phone: 314-653-5630 Fax: 314-653-4099 | |
Dr. Beverly Kraemer, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 660 Office Pkwy, Saint Louis, MO 63141 Phone: 314-991-8015 Fax: 314-991-0691 |